Home

Profiles

Mount Sinai Doctors

Thalia Robakis, MD, PhD

Psychiatry

No Patient Experience Ratings

About Me
Clinical Focus
Education & Certifications
Awards
Research
Insurance
Publications
Industry Relationships

About Me

Dr. Robakis is a psychiatrist with clinical and research interests in perinatal mood disorders and in the contribution of early life experiences to adult mental health and illness. She completed her M.D. as well as a Ph.D. in developmental neurobiology at Columbia University’s Medical Scientist Training Program, residency training in psychiatry at Stanford University School of Medicine, and a research fellowship in perinatal mood disorders also at Stanford. She is an expert in the management of psychiatric disorders in pregnancy and the postpartum period. She takes a holistic approach to patient care including providing or recommending behavioral, psychosocial, psychotherapeutic, pharmacological, and neurostimulatory interventions as necessary and appropriate for each mother/infant dyad. She wants all new moms to remember that the best gift they can give their babies is a calm, happy, and well-rested mother.

Language

English

Position

SENIOR FACULTY | Psychiatry

Hospital Affiliations

Mount Sinai Morningside
Mount Sinai Beth Israel
Mount Sinai Brooklyn
Mount Sinai Queens
The Mount Sinai Hospital
Mount Sinai West

Research Topics

Developmental Neurobiology, Epigenetics, Epigenomics, Neurobiology, Psychiatry

Download the CV

About Me

Language

English

Position

SENIOR FACULTY | Psychiatry

Hospital Affiliations

Mount Sinai Morningside
Mount Sinai Beth Israel
Mount Sinai Brooklyn
Mount Sinai Queens
The Mount Sinai Hospital
Mount Sinai West

Research Topics

Developmental Neurobiology, Epigenetics, Epigenomics, Neurobiology, Psychiatry

Download the CV

Clinical Focus

Anxiety
Behavioral Health
Bipolar Disorder
Depression
Menopause
Mood Disorders
Obsessive-Compulsive Disorder
Postpartum Depression
Premenstrual Dysphoric Disorder

Anxiety
Behavioral Health
Bipolar Disorder
Depression
Menopause
Mood Disorders
Obsessive-Compulsive Disorder
Postpartum Depression
Premenstrual Dysphoric Disorder

Education

MD, Columbia University College of Physicians & Surgeons

n/a, Stanford University Department of Psychiatry

Residency, Psychiatry

Stanford University Medical Center

Awards

2019

Maternal and Child Health Research Institute Clinician Educator Grant

Stanford University

2019

Departmental Innovator Scholarly Project Grant

Stanford University Department of Psychiatry

2018

Precision Health and Integrated Diagnostics seed funding

Stanford University

2015

NARSAD Young Investigator Grant

Brain and Behavior Research Foundation

2013

Biennial Perinatal Mental Health Conference Travel Award

Perinatal Mental Health Conference

2013

APA Junior Investigator Research Colloquium participant

American Psychiatric Association

2002

Hellenic Medical Society of New York Medical Scholarship

Hellenic Medical Society of New York

1999

Phi Beta Kappa

Barnard College

Research

Insecure attachment style is a major predictive factor for perinatal depression. Alterations in DNA methylation associated with perinatal depression may help identify biological pathways through which early life experiences exert their effects on outcomes in adulthood. Distinct patterns of DNA methylation associated with attachment insecurity, early life stress, and concurrent mood disruption in pregnant and postpartum women suggest that difficulty with the role transition to parenthood, a phenomenon long described by psychotherapists, may be a primary contributor to depression specific to the perinatal period. This work represents a contribution to the ongoing synthesis of psychological, psychiatric, and neurobiological paradigms.

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Publications:42

Selected Publications

In utero exposure to ADHD medication and long-term offspring outcomes. Kathrine Bang Madsen, Thalia K. Robakis, Xiaoqin Liu, Natalie Momen, Henrik Larsson, Julie Werenberg Dreier, Helene Kildegaard, Jane Bjerg Groth, Jeffrey H. Newcorn, Per Hove Thomsen, Trine Munk-Olsen, Veerle Bergink. Molecular Psychiatry
Insulin resistance and accelerated cognitive aging. Fahim Abbasi, Thalia K. Robakis, Alison Myoraku, Kathleen T. Watson, Tonita Wroolie, Natalie L. Rasgon. Psychoneuroendocrinology
Neurodevelopment in school-aged children after intrauterine exposure to antipsychotics. Lisanne Schrijver, Thalia K. Robakis, Astrid M. Kamperman, Hilmar Bijma, Adriaan Honig, Inge L. van Kamp, Witte J.G. Hoogendijk, Veerle Bergink, Eline M.P. Poels. Acta Psychiatrica Scandinavica

View All Publications

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Robakis did not report having any of the following types of financial relationships with industry and other outside entities during 2023 and/or 2024: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.